On May 13, 2025, Agilon Health (AGL, Financial) received an updated stock analysis from Wells Fargo, led by analyst Stephen Baxter. The firm has maintained its “Overweight” rating for Agilon Health, suggesting continued optimistic outlook despite recent adjustments.
In parallel with this rating affirmation, Wells Fargo has revised its price target for Agilon Health (AGL, Financial), lowering it to $5.00 from the previous target of $6.00. This represents a 16.67% reduction in the price target, signaling a recalibration of expected performance assessments for the company.
The price target adjustment reflects Wells Fargo’s updated analysis while still maintaining confidence in the long-term growth potential of Agilon Health (AGL, Financial), as evidenced by the consistent “Overweight” rating.
Investors in Agilon Health (AGL, Financial) will find these updates pertinent as they consider future investment strategies and market positions. Monitoring subsequent analyst updates could provide further insights into market expectations for Agilon Health.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 14 analysts, the average target price for Agilon Health Inc (AGL, Financial) is $4.25 with a high estimate of $7.50 and a low estimate of $1.00. The average target implies an
upside of 54.96%
from the current price of $2.75. More detailed estimate data can be found on the Agilon Health Inc (AGL) Forecast page.
Based on the consensus recommendation from 21 brokerage firms, Agilon Health Inc’s (AGL, Financial) average brokerage recommendation is currently 2.8, indicating “Hold” status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Agilon Health Inc (AGL, Financial) in one year is $22.30, suggesting a
upside
of 712.39% from the current price of $2.745. GF Value is GuruFocus’ estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business’ performance. More detailed data can be found on the Agilon Health Inc (AGL) Summary page.
Source: gurufocus.com
